NAS:MDCO (USA) Also Trade In: Germany

The Medicines Co $ 84.9 0 (0%)

Volume:
0
Avg Vol (1m):
0
Market Cap $:
6.79 Bil
Enterprise Value $:
6.79 Bil
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected with MDCO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for The Medicines Co () from 2000 to Oct 29 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. The Medicines stock (MDCO) PE ratio as of Oct 29 2020 is 0. More Details

The Medicines PE Ratio (TTM) Chart

EMBED

The Medicines PE Ratio (TTM) Historical Data

Total 1047
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12
The Medicines PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-10-290.0 2019-11-050.0
2020-01-060.0 2019-11-040.0
2020-01-030.0 2019-11-010.0
2020-01-020.0 2019-10-310.0
2020-01-010.0 2019-10-300.0
2019-12-310.0 2019-10-290.0
2019-12-300.0 2019-10-280.0
2019-12-270.0 2019-10-250.0
2019-12-260.0 2019-10-240.0
2019-12-250.0 2019-10-230.0
2019-12-240.0 2019-10-220.0
2019-12-230.0 2019-10-210.0
2019-12-200.0 2019-10-180.0
2019-12-190.0 2019-10-170.0
2019-12-180.0 2019-10-160.0
2019-12-170.0 2019-10-150.0
2019-12-160.0 2019-10-140.0
2019-12-130.0 2019-10-110.0
2019-12-120.0 2019-10-100.0
2019-12-110.0 2019-10-090.0
2019-12-100.0 2019-10-080.0
2019-12-090.0 2019-10-070.0
2019-12-060.0 2019-10-040.0
2019-12-050.0 2019-10-030.0
2019-12-040.0 2019-10-020.0
2019-12-030.0 2019-10-010.0
2019-12-020.0 2019-09-300.0
2019-11-290.0 2019-09-270.0
2019-11-280.0 2019-09-260.0
2019-11-270.0 2019-09-250.0
2019-11-260.0 2019-09-240.0
2019-11-250.0 2019-09-230.0
2019-11-220.0 2019-09-200.0
2019-11-210.0 2019-09-190.0
2019-11-200.0 2019-09-180.0
2019-11-190.0 2019-09-170.0
2019-11-180.0 2019-09-160.0
2019-11-150.0 2019-09-130.0
2019-11-140.0 2019-09-120.0
2019-11-130.0 2019-09-110.0
2019-11-120.0 2019-09-100.0
2019-11-110.0 2019-09-090.0
2019-11-080.0 2019-09-060.0
2019-11-070.0 2019-09-050.0
2019-11-060.0 2019-09-040.0

The Medicines PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Drug Manufacturers » NAICS : 325412 NAICS : 2834
Traded in other countries MZN.Germany MDCO.USA
Address 8 Sylvan Way, Parsippany, NJ, USA, 07054
The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.